Retractable Technologies (RVP) Total Non-Current Liabilities (2018 - 2026)
Retractable Technologies' (RVP) quarterly Total Non-Current Liabilities came in at $13.7 million in Q2 2026, up 41.19% on a YoY basis from $9.7 million in Q2 2025, and up 25.94% quarter-over-quarter from $10.9 million in Q1 2026.
Analysis
Retractable Technologies (RVP) Total Non-Current Liabilities (2018 - 2026) Analysis & Trends
Retractable Technologies (RVP) has reported Total Non-Current Liabilities for 9 consecutive years, with $13.7 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Total Non-Current Liabilities rose 41.19% year-over-year to $13.7 million; the trailing twelve-month figure through Jun 2026 stood at $13.7 million (up 41.19% YoY), and the FY2025 full-year result was $10.1 million, up 4.62% from the prior year.
- Total Non-Current Liabilities rose to $13.7 million in Q2 2026 per RVP's latest filing, from $10.9 million in the prior quarter.
- Across five years, Total Non-Current Liabilities topped out at $30.2 million in Q1 2022 and bottomed at $8.0 million in Q1 2024.
- Historically, Total Non-Current Liabilities has averaged $12.3 million across 5 years, with a median of $10.4 million in 2023.
- The sharpest annual moves came in 2022 and 2026: Total Non-Current Liabilities plunged 63.88% in 2022, then surged 41.19% in 2026.
- Over 5 years, Total Non-Current Liabilities stood at $13.7 million in 2022, then retreated by 22.37% to $10.6 million in 2023, then slipped by 8.77% to $9.7 million in 2024, then climbed by 4.62% to $10.1 million in 2025, then jumped by 35.29% to $13.7 million in 2026.
- According to Business Quant data, Total Non-Current Liabilities over the past three periods registered $13.7 million, $10.9 million, and $10.1 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Becton Dickinson | 48.41 Bn | 47.55 Bn | 2.32 Bn | 23.92 Bn |
| 2 | Medline | 27.78 Bn | 25.10 Bn | 2.22 Bn | 17.56 Bn |
| 3 | West Pharmaceutical Services | 24.42 Bn | 23.98 Bn | 329.20 Mn | 996.30 Mn |
| 4 | Baxter International | 12.49 Bn | 10.34 Bn | 1.03 Bn | 12.41 Bn |
| 5 | Stevanato Group S.p.A | 5.70 Bn | 5.59 Bn | 100.91 Mn | -89.27 Mn |
| 6 | Acme United | 235.29 Mn | 230.25 Mn | 26.69 Mn | 75.19 Mn |
| 7 | Rockwell Medical | 31.39 Mn | 6.60 Mn | 3.24 Mn | - |
| 8 | Retractable Technologies | 21.15 Mn | -18.72 Mn | 190,852.00 | 13.70 Mn |
| 9 | United Health Products | 8.85 Mn | 8.82 Mn | - | 4.54 Mn |
| 10 | Cuprina Holdings (Cayman) | 7.88 Mn | 4.76 Mn | - | 333,758.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 13.70 Mn |
| Mar 31, 2026 | 10.88 Mn |
| Dec 31, 2025 | 10.13 Mn |
| Sep 30, 2025 | 10.25 Mn |
| Jun 30, 2025 | 9.70 Mn |
| Mar 31, 2025 | 10.31 Mn |
| Dec 31, 2024 | 9.68 Mn |
| Sep 30, 2024 | 9.01 Mn |
| Jun 30, 2024 | 8.49 Mn |
| Mar 31, 2024 | 8.03 Mn |
| Dec 31, 2023 | 10.61 Mn |
| Sep 30, 2023 | 10.57 Mn |
| Jun 30, 2023 | 10.26 Mn |
| Mar 31, 2023 | 11.75 Mn |
| Dec 31, 2022 | 13.67 Mn |
| Sep 30, 2022 | 16.59 Mn |
| Jun 30, 2022 | 17.91 Mn |
| Mar 31, 2022 | 30.17 Mn |
| Dec 31, 2021 | 37.14 Mn |
| Sep 30, 2021 | 38.09 Mn |